Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone morphogenetic protein receptor type-1B (BMPR1B) is a transmembrane serine/threonine kinase receptor for bone morphogenetic proteins (BMPs). It plays a critical role in embryogenesis, endochondral bone formation, and various cellular differentiation processes. Upon ligand binding, BMPR1B initiates intracellular signaling by phosphorylating SMAD effectors or activating non-canonical pathways such as MAPK. Mutations or dysregulation of BMPR1B have been linked with several human diseases, including primary pulmonary hypertension, acromesomelic dysplasia-type 3, and brachydactyly.
Not applicable, as no specific drugs are mentioned in the context information that directly target this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone morphogenetic protein receptor type-1B (BMPR1B).